🇺🇸 FDA
Patent

US 7638507

Compositions for treatment of inflammatory diseases

granted A61KA61K31/13A61K31/198

Quick answer

US patent 7638507 (Compositions for treatment of inflammatory diseases) held by The Board of Regents of the University of Oklahoma expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/13, A61K31/198, A61K31/355, A61K31/375